Understanding NRXN1: A Potential Drug Target and Biomarker (G9378)

Target Name: NRXN1

NCBI ID: G9378

NRXN1

Understanding NRXN1: A Potential Drug Target and Biomarker

NRXN1 (FLJ35941) is a protein that is expressed in various tissues throughout the body, including the brain, heart, kidneys, and intestines. It is a member of the neurotrophic factor receptor family, which is a group of transmembrane proteins that play a critical role in the development and maintenance of neural tissue.

NRXN1 has been identified as a potential drug target and has been shown to play a role in a variety of biological processes, including neuroprotection, neurodegeneration, and pain perception. Its expression has also been associated with several diseases, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis.

One of the most promising aspects of NRXN1 is its potential as a drug target. Researchers have identified several potential drugs that can interact with NRXN1 and have shown that these drugs can promote neurotrophic factor receptor function. These drugs include statins, which are commonly used to treat heart disease, and drugs that can modulate the activity of ion channels, such as kalium channel blockers.

In addition to its potential as a drug target, NRXN1 is also a promising biomarker for several diseases. Its expression has been shown to be elevated in the brains of individuals with Alzheimer's disease and has been used as a diagnostic marker for this disease. Similarly, it has been shown to be elevated in the brains of individuals with Parkinson's disease, and has been used as a potential diagnostic marker for this disease.

NRXN1 has also been shown to be involved in pain perception and has been used as a potential drug target for pain relief. Its expression has been shown to be elevated in the brains of individuals with neuropathic pain, and studies have suggested that targeting NRXN1 may be an effective way to treat this type of pain.

Despite its potential as a drug target and biomarker, NRXN1 is still a relatively little-known protein. There is currently limited research on the molecular mechanisms that regulate its expression and its role in different biological processes. However, studies have shown that NRXN1 is involved in several important biological processes, including neurotrophic factor signaling, ion channel regulation, and pain perception.

In conclusion, NRXN1 is a protein that has the potential to be a drug target and biomarker for several diseases. Its expression has been shown to be involved in several important biological processes and its potential as a drug target and biomarker is currently being investigated. Further research is needed to fully understand its role in different biological processes and its potential as a drug.

Protein Name: Neurexin 1

Functions: Cell surface protein involved in cell-cell-interactions, exocytosis of secretory granules and regulation of signal transmission. Function is isoform-specific. Alpha-type isoforms have a long N-terminus with six laminin G-like domains and play an important role in synaptic signal transmission. Alpha-type isoforms play a role in the regulation of calcium channel activity and Ca(2+)-triggered neurotransmitter release at synapses and at neuromuscular junctions. They play an important role in Ca(2+)-triggered exocytosis of secretory granules in pituitary gland. They may affect their functions at synapses and in endocrine cells via their interactions with proteins from the exocytotic machinery. Likewise, alpha-type isoforms play a role in regulating the activity of postsynaptic NMDA receptors, a subtype of glutamate-gated ion channels. Both alpha-type and beta-type isoforms may play a role in the formation or maintenance of synaptic junctions via their interactions (via the extracellular domains) with neuroligin family members, CBLN1 or CBLN2. In vitro, triggers the de novo formation of presynaptic structures. May be involved in specification of excitatory synapses. Alpha-type isoforms were first identified as receptors for alpha-latrotoxin from spider venom

The "NRXN1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NRXN1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets